Merger Agreements in the Biotechnology Industry

626 Contracts & Agreements

Browse by Company

AbbVie Inc. (2 contracts)
ABEONA THERAPEUTICS INC. (4)
ACCELERON PHARMA INC (1)
ACHIEVE LIFE SCIENCES, INC. (3)
Acorda Therapeutics (3)
Adamas Pharmaceuticals Inc (1)
Adaptimmune Therapeutics PLC (2)
Adhera Therapeutics, Inc. (2)
ADiTx Therapeutics, Inc. (4)
ADMA BIOLOGICS, INC. (1)
ADURO BIOTECH, INC. (3)
Advaxis, Inc. (4)
Aeglea BioTherapeutics, Inc. (3)
AgeX Therapeutics, Inc. (2)
AILERON THERAPEUTICS INC (1)
Aimmune Therapeutics, Inc. (1)
AKCEA THERAPEUTICS, INC. (1)
Akebia Therapeutics, Inc. (2)
Akouos, Inc. (1)
ALBIREO PHARMA, INC. (1)
Aldeyra Therapeutics, Inc. (1)
Alexion Pharmaceuticals (9)
Alkermes plc. (1)
Alliqua BioMedical, Inc. (9)
Alpha Healthcare Acquisition Corp. (1)
ALPINE IMMUNE SCIENCES, INC. (1)
Altimmune, Inc. (4)
Amgen Inc. (8)
AMICUS THERAPEUTICS, INC. (5)
AmpliPhi Biosciences Corp (3)
Anchiano Therapeutics Ltd. (1)
Anika Therapeutics (2)
APPLIED GENETIC TECHNOLOGIES CORP (1)
Applied Molecular Transport Inc. (1)
Aprea Therapeutics, Inc. (1)
AQUINOX PHARMACEUTICALS, INC (1)
Aravive, Inc. (1)
ARCA biopharma, Inc. (5)
ARENA PHARMACEUTICALS INC (1)
ARROWHEAD PHARMACEUTICALS, INC. (2)
Arsanis, Inc. (3)
ARYA Sciences Acquisition Corp II (3)
ASSEMBLY BIOSCIENCES, INC. (1)
Athenex, Inc. (1)
AVEO PHARMACEUTICALS INC (1)
Avid Bioservices, Inc. (1)
AVROBIO, Inc. (1)
Ayala Pharmaceuticals, Inc. (1)
AzurRx BioPharma, Inc. (2)
Beam Therapeutics Inc. (1)
Big Cypress Acquisition Corp. (1)
BioCardia, Inc. (4)
BIOCRYST PHARMACEUTICALS INC (1)
Biogen Inc. (2)
Biohaven Pharmaceutical Holding Co Ltd. (3)
BioRestorative Therapies, Inc. (1)
BIOSPECIFICS TECHNOLOGIES CORP (1)
BIOTIME INC (2)
BIOVIE INC. (1)
BIOXYTRAN, INC (2)
Bison Capital Acquisition Corp. (4)
Blueprint Medicines Corp (1)
Bone Biologics Corp (2)
BridgeBio Pharma, Inc. (2)
CALADRIUS BIOSCIENCES, INC. (4)
Calyxt, Inc. (2)
CANCER GENETICS, INC (4)
CAPRICOR THERAPEUTICS, INC. (4)
CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (2)
CareDx, Inc. (1)
CASI Pharmaceuticals, Inc. (2)
CASTLE BIOSCIENCES INC (2)
CATABASIS PHARMACEUTICALS INC (1)
CATALYST BIOSCIENCES, INC. (3)
CATALYST PHARMACEUTICALS, INC. (1)
Celldex Therapeutics, Inc. (1)
Cellectar Biosciences, Inc. (1)
Cellular Biomedicine Group, Inc. (5)
Centessa Pharmaceuticals Ltd (1)
Chanticleer Holdings, Inc. (4)
Chardan Healthcare Acquisition 2 Corp. (2)
Chardan Healthcare Acquisition Corp. (5)
Checkmate Pharmaceuticals, Inc. (1)
ChemoCentryx, Inc. (1)
CHIMERIX INC (1)
CLEVELAND BIOLABS INC (1)
CM Life Sciences III Inc. (3)
Coherus BioSciences, Inc. (2)
Comera Life Sciences Holdings, Inc. (1)
Conatus Pharmaceuticals Inc. (1)
CONCERT PHARMACEUTICALS, INC. (1)
Constellation Alpha Capital Corp. (1)
CONSTELLATION PHARMACEUTICALS INC (1)
Corbus Pharmaceuticals Holdings, Inc. (1)
Cortexyme, Inc. (1)
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (2)
CTD HOLDINGS INC (2)
CTI BIOPHARMA CORP (2)
Cullinan Oncology, LLC (1)
Cybrdi, Inc. (1)
CytoDyn Inc. (1)
CYTRX CORP (1)
Decibel Therapeutics, Inc. (1)
Deciphera Pharmaceuticals, Inc. (2)
DelMar Pharmaceuticals, Inc. (1)
Dermira, Inc. (1)
Dicerna Pharmaceuticals Inc (1)
Diffusion Pharmaceuticals Inc. (6)
Digital Development Partners, Inc. (2)
Dynamics Special Purpose Corp. (2)
Edge Therapeutics, Inc. (4)
Eidos Therapeutics, Inc. (1)
Eiger BioPharmaceuticals, Inc. (4)
Eliem Therapeutics, Inc. (1)
Emerald Bioscience, Inc. (2)
Emergent BioSolutions Inc. (2)
Entasis Therapeutics Holdings Inc. (1)
Environmental Impact Acquisition Corp (2)
Epizyme, Inc. (1)
Equillium, Inc. (2)
Erasca, Inc. (1)
EVOLUTIONARY GENOMICS, INC. (2)
EXACT SCIENCES CORP (4)
Exelixis (1)
EXICURE, INC. (2)
Fibrocell Science, Inc. (1)
FIVE PRIME THERAPEUTICS INC (1)
Flex Pharma, Inc. (3)
Flexion Therapeutics Inc (1)
FLUOROPHARMA MEDICAL, INC. (2)
Forma Therapeutics Holdings, Inc., (1)
Fortress Biotech, Inc. (3)
Forty Seven, Inc. (1)
Frequency Therapeutics, Inc. (1)
FS Development Corp. (2)
FS Development Corp. II (3)
Gemphire Therapeutics Inc. (2)
Gene Biotherapeutics, Inc. (2)
GeoVax Labs, Inc. (2)
Gilead Sciences (12)
Global Blood Therapeutics, Inc. (1)
Graphite Bio, Inc. (7)
GT Biopharma, Inc. (1)
GTX INC (2)
GX Acquisition Corp. (2)
HALOZYME THERAPEUTICS INC (1)
Harpoon Therapeutics, Inc. (1)
HEAT BIOLOGICS, INC. (1)
HedgePath Pharmaceuticals, Inc. (1)
HilleVax, Inc. (1)
HISTOGENICS CORP (2)
Homology Medicines, Inc. (2)
Icosavax, Inc. (1)
IDERA PHARMACEUTICALS, INC. (3)
Imago BioSciences, Inc. (1)
IMMUNE PHARMACEUTICALS INC (5)
ImmunoCellular Therapeutics, Ltd. (1)
IMMUNOGEN INC (1)
Immunome Inc. (1)
IMMUNOMEDICS INC (1)
Incyte (2)
Inhibrx, Inc. (1)
INOVIO PHARMACEUTICALS, INC. (1)
INSMED Inc (1)
Inspyr Therapeutics, Inc. (1)
Intec Pharma Ltd. (2)
INTERCEPT PHARMACEUTICALS, INC. (1)
INTREXON CORP (2)
Invitae Corp (11)
IONIS PHARMACEUTICALS INC (1)
IOVANCE BIOTHERAPEUTICS, INC. (1)
Isoray, Inc. (4)
Jounce Therapeutics, Inc. (1)
Kadmon Holdings, Inc. (1)
Karuna Therapeutics, Inc. (1)
KBL MERGER CORP. IV (4)
Kindred Biosciences, Inc. (2)
Kinnate Biopharma Inc. (1)
Kura Oncology, Inc. (2)
LA JOLLA PHARMACEUTICAL CO (7)
LEAP THERAPEUTICS, INC. (1)
Leisure Acquisition Corp. (2)
LifeSci Acquisition Corp. (2)
Ligand Pharmaceuticals Incorporated (16)
LogicBio Therapeutics, Inc. (1)
MADRIGAL PHARMACEUTICALS, INC. (1)
Magenta Therapeutics, Inc. (1)
MATEON THERAPEUTICS INC (4)
Matinas BioPharma Holdings, Inc. (2)
MEDICINOVA INC (1)
Medovex Corp. (2)
MEI Pharma, Inc. (1)
MeiraGTx Holdings plc (2)
Metacrine, Inc. (1)
Millendo Therapeutics, Inc. (3)
MiMedx Group, Inc. (4)
Minerva Neurosciences, Inc. (1)
MIRAGEN THERAPEUTICS, INC. (2)
Mirati Therapeutics, Inc. (1)
Molecular Templates, Inc. (1)
Moleculin Biotech, Inc. (1)
Momenta Pharmaceuticals, Inc. (1)
Myovant Sciences Ltd. (1)
Myriad Genetics, Inc. (3)
NantKwest, Inc. (4)
Neurotrope, Inc. (6)
NEWLINK GENETICS CORP (2)
NTN BUZZTIME INC (1)
NUTRA PHARMA CORP (1)
Ohr Pharmaceutical Inc (3)
Olivia Ventures, Inc. (1)
OncBioMune Pharmaceuticals, Inc (2)
OncoCyte Corp (4)
OPGEN INC (1)
Ophthotech Corp. (1)
Opko Health, Inc. (5)
Organogenesis Holdings Inc. (13)
ORGANOVO HOLDINGS, INC. (6)
Orgenesis Inc. (1)
Oyster Point Pharma, Inc. (1)
Pfenex Inc. (1)
PORTOLA PHARMACEUTICALS INC (1)
Poseida Therapeutics, Inc. (2)
Prevail Therapeutics Inc. (1)
Principia Biopharma Inc. (1)
Progenics Pharmaceuticals, Inc. (2)
Prometheus Biosciences, Inc. (1)
Protagenic Therapeutics, Inc. (5)
Protalix BioTherapeutics, Inc. (1)
PROTEON THERAPEUTICS INC (2)
PROTEOSTASIS THERAPEUTICS, INC. (4)
PTC THERAPEUTICS, INC. (1)
PUMA BIOTECHNOLOGY, INC. (1)
Radius Health, Inc. (2)
Rasna Therapeutics Inc. (2)
REGENXBIO Inc. (1)
Relay Therapeutics, Inc. (1)
Retrophin, Inc. (1)
Revolution Medicines, Inc. (3)
REXAHN PHARMACEUTICALS, INC. (3)
Rezolute, Inc. (1)
RITTER PHARMACEUTICALS INC (1)
ROCKET PHARMACEUTICALS, INC. (2)
Sana Biotechnology, Inc. (4)
SANGAMO THERAPEUTICS, INC (1)
Sarepta Therapeutics, Inc. (1)
Savara Inc (3)
SEATTLE GENETICS INC (2)
SELLAS Life Sciences Group, Inc. (2)
Sesen Bio, Inc. (1)
Sierra Oncology, Inc. (1)
Sigilon Therapeutics, Inc. (1)
Silverback Therapeutics, Inc. (3)
SOLENO THERAPEUTICS INC (1)
Solid Biosciences Inc. (5)
Sorrento Therapeutics, Inc. (12)
Spectrum Pharmaceuticals, Inc. (4)
SPHERIX INC (5)
Spinning Eagle Acquisition Corp. (4)
Spring Bank Pharmaceuticals, Inc. (3)
Sun BioPharma, Inc. (4)
SUNESIS PHARMACEUTICALS INC (1)
Surface Oncology, Inc. (1)
SYNLOGIC, INC. (4)
Synthetic Biologics, Inc. (1)
Syros Pharmaceuticals, Inc. (1)
Talaris Therapeutics, Inc. (1)
TCR2 THERAPEUTICS INC. (1)
TENAX THERAPEUTICS, INC. (1)
Therapeutics Acquisition Corp. (1)
Tocagen Inc (1)
Translate Bio, Inc. (1)
Turning Point Therapeutics, Inc. (1)
TYME TECHNOLOGIES, INC. (1)
Ultragenyx Pharmaceutical Inc. (1)
United Therapeutics Corp (1)
Unum Therapeutics Inc. (1)
Vaccitech plc (3)
Vaxart, Inc. (5)
VERACYTE, INC. (2)
Vertex Pharmaceuticals Inc (2)
VICAL INC (2)
Viela Bio, Inc. (1)
Vir Biotechnology, Inc. (1)
VistaGen Therapeutics, Inc. (2)
VITRO DIAGNOSTICS INC (1)
WINDTREE THERAPEUTICS INC (1)
XOMA Corp (1)
ZAFGEN, INC. (2)
ZIOPHARM ONCOLOGY INC (1)

Recent Contracts

Agreement and Plan of Merger and Reorganization (Emerald Bioscience, Inc., Filed With SEC on March 22, 2024)
Agreement and Plan of Merger, dated March 13, 2024, by and among First Wave BioPharma, Inc. IMMUNO Merger Sub I, Inc., IMMUNO Merger Sub II, LLC, and ImmunogenX, Inc (AzurRx BioPharma, Inc., Filed With SEC on March 14, 2024)
Form of Merger Warrant (Chardan Healthcare Acquisition Corp., Filed With SEC on March 6, 2024)
Agreement and Plan of Merger, dated March 6, 2024, by and among BiomX Inc., BTX Merger Sub I, Inc., BTX Merger Sub II, LLC and Adaptive Phage Therapeutics, Inc (Chardan Healthcare Acquisition Corp., Filed With SEC on March 6, 2024)
Third Amendment to Agreement and Plan of Merger dated as of February 29, 2024, by and among Aditxt, Inc., Adicure, Inc. and Evofem Biosciences, Inc (ADiTx Therapeutics, Inc., Filed With SEC on March 4, 2024)
Agreement and Plan of Merger, dated August 5, 2021, by and among EQRx, Inc. (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx,... (Revolution Medicines, Inc., Filed With SEC on February 26, 2024)
Agreement and Plan of Merger between the Company, Kinnate and Merger Sub, dated February 16, 2024 (XOMA Corp, Filed With SEC on February 16, 2024)
Agreement and Plan of Merger, dated February 16, 2024, by and among XOMA Corporation, XRA 1 Corp. and Kinnate Biopharma Inc (Kinnate Biopharma Inc., Filed With SEC on February 16, 2024)
Agreement and Plan of Merger, dated February 11, 2024, among CymaBay Therapeutics, Inc., Gilead Sciences, Inc. and Pacific Merger Sub, Inc (Gilead Sciences, Filed With SEC on February 12, 2024)
Second Amendment to Agreement and Plan of Merger dated as of January 8, 2024, by and among Aditxt, Inc., Adicure, Inc. and Evofem Biosciences, Inc (ADiTx Therapeutics, Inc., Filed With SEC on February 2, 2024)
Agreement and Plan of Merger, dated as of January 30, 2024, by and among AVRO, Aspen Merger Subsidiary, Inc. and Tectonic (AVROBIO, Inc., Filed With SEC on January 30, 2024)
Agreement and Plan of Merger, dated as of January 22, 2024, by and among Inhibrx, Inc., Aventis Inc., and Art Acquisition Sub, Inc (Inhibrx, Inc., Filed With SEC on January 23, 2024)
First Amendment to Agreement and Plan of Merger dated as of January 8, 2024, by and among Aditxt, Inc., Adicure, Inc. and Evofem Biosciences, Inc (ADiTx Therapeutics, Inc., Filed With SEC on January 9, 2024)
Agreement and Plan of Merger, by and among Merck Sharp & Dohme LLC, Harpoon Therapeutics, Inc., and Hawaii Merger Sub, Inc., dated January 7, 2024 (Harpoon Therapeutics, Inc., Filed With SEC on January 8, 2024)
Agreement and Plan of Merger, dated as of December 22, 2023, by and among Karuna Therapeutics, Inc., Bristol-Myers Squibb Company and Miramar Merger Sub Inc (Karuna Therapeutics, Inc., Filed With SEC on December 22, 2023)
Agreement and Plan of Merger, dated June 22, 2023, by and among the Company, Aspen Merger Sub I, Inc., Sequoia Merger Sub II, LLC and Spyre Therapeutics, Inc (Aeglea BioTherapeutics, Inc., Filed With SEC on December 22, 2023)
Agreement and Plan of Merger, dated as of November 16, 2023, by and among Homology Medicines, Inc., Kenobi Merger Sub, Inc., and Q32 Bio Inc (Homology Medicines, Inc., Filed With SEC on December 18, 2023)
Agreement and Plan of Merger, dated as of December 11, 2023, by and among AstraZeneca Finance and Holdings Inc., Isochrone Merger Sub Inc. and Icosavax, Inc (Icosavax, Inc., Filed With SEC on December 12, 2023)
Agreement and Plan of Merger among Aditxt, Inc., Adicure, Inc. and Evofem Biosciences, Inc. dated as of December 11, 2023 (ADiTx Therapeutics, Inc., Filed With SEC on December 12, 2023)
Support Agreement, dated as of December 6, 2023, by and among AbbVie Inc., Symphony Harlan, LLC, Symphony Harlan Merger Sub, Inc. and BC Perception Holdings, LP (ARYA Sciences Acquisition Corp II, Filed With SEC on December 7, 2023)
Agreement and Plan of Merger, dated as of December 6, 2023, by and among AbbVie Inc., Symphony Harlan LLC, Symphony Harlan Merger Sub, Inc., and Cerevel Therapeutics Holdings, Inc (ARYA Sciences Acquisition Corp II, Filed With SEC on December 7, 2023)
Employee Incentive Compensation Plan, to be in effect upon completion of the merger (Graphite Bio, Inc., Filed With SEC on December 6, 2023)
Outside Director Compensation Policy, to be in effect upon completion of the merger (Graphite Bio, Inc., Filed With SEC on December 6, 2023)
Executive Change in Control and Severance Policy and form of participation agreement, to be in effect upon completion of the merger (Graphite Bio, Inc., Filed With SEC on December 6, 2023)
Form of Employment Offer Letter between LENZ Therapeutics, Inc., and Marc Odrich, to be in effect upon completion of the merger (Graphite Bio, Inc., Filed With SEC on December 6, 2023)
Form of Employment Offer Letter between LENZ Therapeutics, Inc., and Shawn Olsson, to be in effect upon completion of the merger (Graphite Bio, Inc., Filed With SEC on December 6, 2023)
Form of Employment Offer Letter between LENZ Therapeutics, Inc., and Evert Schimmelpennink, to be in effect upon completion of the merger (Graphite Bio, Inc., Filed With SEC on December 6, 2023)
Agreement and Plan of Merger, dated as of November 30, 2023, among the Company, Parent, Intermediate Sub and Purchaser (IMMUNOGEN INC, Filed With SEC on November 30, 2023)
Agreement and Plan of Merger, dated November 16, 2023, by and among Homology Medicines, Inc., Kenobi Merger Sub, Inc., and Q32 Bio Inc (Homology Medicines, Inc., Filed With SEC on November 16, 2023)
Agreement and Plan of Merger, dated as of November 14, 2023, by and among Graphite Bio, Inc., Generate Merger Sub, Inc. and Lenz Therapeutics, Inc (Graphite Bio, Inc., Filed With SEC on November 15, 2023)
Agreement and Plan of Merger, dated June 22, 2023, by and among Aeglea BioTherapeutics, Inc. Aspen Merger Sub I, Inc., Sequoia Merger Sub II, LLC and Spyre Therapeutics, Inc (Aeglea BioTherapeutics, Inc., Filed With SEC on November 15, 2023)
Agreement and Plan of Merger, dated October 31, 2023, by and among Aileron Therapeutics, Inc., AT Merger Sub I, Inc., AT Merger Sub II, LLC and Lung Therapeutics, Inc (AILERON THERAPEUTICS INC, Filed With SEC on October 31, 2023)
Agreement and Plan of Merger and Reorganization, by and among the Company, Merger Sub, and Biosight, dated as of July 26, 2023 (incorporated by Reference to Exhibit 2.1 to the... (Advaxis, Inc., Filed With SEC on October 20, 2023)
Agreement and Plan of Merger, dated as of October 8, 2023, by and among Bristol-Myers Squibb Company, Vineyard Merger Sub Inc., and Mirati Therapeutics, Inc (Mirati Therapeutics, Inc., Filed With SEC on October 10, 2023)
Agreement and Plan of Merger, dated as of October 2, 2023, by and among Eli Lilly and Company, Yosemite Falls Acquisition Corporation and POINT Biopharma Global Inc (Therapeutics Acquisition Corp., Filed With SEC on October 3, 2023)
Agreement and Plan of Merger, dated September 26, 2023, among Intercept Pharmaceuticals, Inc., Alfasigma S.p.A. and Interstellar Acquisition Inc (INTERCEPT PHARMACEUTICALS, INC., Filed With SEC on September 26, 2023)
Agreement and Plan of Merger, dated as of September 21, 2023, by and among Cyclo Therapeutics, Inc., Cameo Merger Sub, Inc. and Applied Molecular Transport Inc (CTD HOLDINGS INC, Filed With SEC on September 21, 2023)
Agreement and Plan of Merger, dated as of September 21, 2023, by and among Cyclo Therapeutics, Inc., Cameo Merger Sub, Inc. and Applied Molecular Transport Inc (Applied Molecular Transport Inc., Filed With SEC on September 21, 2023)
Agreement and Plan of Merger and Reorganization, dated August 29, 2023, by and among AgeX Therapeutics, Inc., Canaria Transaction Corporation and Serina Therapeutics, Inc (AgeX Therapeutics, Inc., Filed With SEC on August 30, 2023)
Agreement and Plan of Merger, dated as of August 8, 2023, by and among Decibel Therapeutics, Inc., Regeneron Pharmaceuticals, Inc., and Symphony Acquisition Sub, Inc (Decibel Therapeutics, Inc., Filed With SEC on August 9, 2023)